Clinical trial

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian…

NCT00131703 · London School of Hygiene and Tropical Medicine, Other · Completed

Key facts

NCT number NCT00131703
Title Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women
Official title A Randomised Double Blind Clinical Trial of Amodiaquine (AQ) and Sulphadoxine-pyrimethamine (SP) Used Singly and in Combination (AQ+SP) Compared With Chloroquine (CQ) in the Treatment of Falciparum Malaria Infection in Pregnancy
Lead sponsor London School of Hygiene and Tropical Medicine, Other
Collaborators Ministry of Health, Ghana
Status Completed
Phase Phase 3
Study type Interventional
Conditions Malaria, Pregnancy
Intervention type Drug
Interventions Amodiaquine, Sulphadoxine-pyrimethamine, Chloroquine
Enrollment 900
Start date Mar 1, 2003
Completion Mar 1, 2005
First posted Aug 19, 2005
Last update posted Mar 4, 2025

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies